When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ENDP - Collegium Pharmaceutical Is A Relatively Safe Opioid Pick For 2020
Endo International plc
Today, we will be studying why Collegium Pharmaceutical (COLL) is an attractive pick in 2020, despite being an opioid player.
Company overview
Collegium Pharmaceutical is a specialty pharmaceutical company with a focus on developing and commercializing pain management medications. The company’s product portfolio includes Nucynta ER and Xtampza ER. The majority of opioid players are struggling under the burden of mounting lawsuits and debt. Collegium seems to be one of the few sturdy survivors in the opioid space and is all set to even post profits in 2020.